Solidoro, P.; Sciarrone, F.; Sidoti, F.; Patrucco, F.; Zanotto, E.; Boffini, M.; Rinaldo, R.F.; Bondi, A.; Albera, C.; Curtoni, A.;
et al. QuantiFERON CMV Test and CMV Serostatus in Lung Transplant: Stratification Risk for Infection, Chronic and Acute Allograft Rejection. Viruses 2024, 16, 1251.
https://doi.org/10.3390/v16081251
AMA Style
Solidoro P, Sciarrone F, Sidoti F, Patrucco F, Zanotto E, Boffini M, Rinaldo RF, Bondi A, Albera C, Curtoni A,
et al. QuantiFERON CMV Test and CMV Serostatus in Lung Transplant: Stratification Risk for Infection, Chronic and Acute Allograft Rejection. Viruses. 2024; 16(8):1251.
https://doi.org/10.3390/v16081251
Chicago/Turabian Style
Solidoro, Paolo, Federico Sciarrone, Francesca Sidoti, Filippo Patrucco, Elisa Zanotto, Massimo Boffini, Rocco Francesco Rinaldo, Alessandro Bondi, Carlo Albera, Antonio Curtoni,
and et al. 2024. "QuantiFERON CMV Test and CMV Serostatus in Lung Transplant: Stratification Risk for Infection, Chronic and Acute Allograft Rejection" Viruses 16, no. 8: 1251.
https://doi.org/10.3390/v16081251
APA Style
Solidoro, P., Sciarrone, F., Sidoti, F., Patrucco, F., Zanotto, E., Boffini, M., Rinaldo, R. F., Bondi, A., Albera, C., Curtoni, A., & Costa, C.
(2024). QuantiFERON CMV Test and CMV Serostatus in Lung Transplant: Stratification Risk for Infection, Chronic and Acute Allograft Rejection. Viruses, 16(8), 1251.
https://doi.org/10.3390/v16081251
